Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/182218
Title: MOLECULAR PERSPECTIVES OF MIMOSINE AS A POTENTIAL ANGIOGENIC INHIBITOR IN COLORECTAL CANCER
Researcher: Shashank Mulukutla
Guide(s): Elango, K
Keywords: Keywords: Colorectal Cancer, Angiogenesis, Mimosine, HCT-116 cells, Angiogenic Cascade, Apoptosis, Cell Cycle Inhibitor, 1,2-DMH
University: JSS University
Completed Date: 2017
Abstract: quotObjective: To understand potential of Mimosine (MMS) and its cell inhibitory ability by in silico, in vitro and in vivo evaluations. newlineMethodology: In silico molecular docking study, in vitro analysis, Nuclear staining and apoptotic evaluation were carried out. In vivo tumor dynamics, hematological panel, antioxidant analysis and biochemical evaluations were performed post induction of tumors. The histopathology and iron degeneration in brain and various behavioral parameters were estimated. newlineResults: The in silico study revealed good binding potentials for MMS towards the proteins of the angiogenic cascade. The in vitro analysis provided the cytotoxic potential of the molecule, cellular uptake limits and its DNA fragmentation pattern in HCT-116 cells. The western blotting evaluation demonstrated that MMS exacerbated the expression of HIF-1A and VEGF-A. Apoptotic evaluation revealed considerable apoptosis in HCT-116 cells. In vivo studies revealed a significant reduction in tumor sizes and counts in animals. The RBC and Hb counts were improved while WBC and platelet counts were stabilized. Antioxidant parameters showed improvement in the concentrations of Catalase, SOD and GSH, while MDA levels were suppressed. Biochemical parameters revealed a normalization of their concentrations and the DNA fragmentation pattern was in conjunction to the earlier obtained result in vitro. WB analysis of three angiogenic protens revealed the enhancement and suppression of MMP-9, Ang-2 and PDGF-A respectively. Histopathological analysis revealed the reduction in aggregation of epithelial nuclei while a significant reduction in infiltration of inflammatory cells. newlineConclusion: The current study was designed and conducted with the sole view of determining the potential of MMS to inhibit the markers of the angiogenic cascade. Higher doses of this molecule appeared to exhibit significant efficacy. MMS could possess the ability to enroll in therapeutic strategies of the future for the effective treatment of CRC newlinequot newline
Pagination: I-X, 1-110p
URI: http://hdl.handle.net/10603/182218
Appears in Departments:College of Pharmacy

Files in This Item:
File Description SizeFormat 
01. certificates.pdfAttached File142.94 kBAdobe PDFView/Open
02. dedication.pdf46.52 kBAdobe PDFView/Open
03. acknowledgement.pdf17.39 kBAdobe PDFView/Open
04. abbreviations, tables and figures.pdf117.39 kBAdobe PDFView/Open
05. contents.pdf74.76 kBAdobe PDFView/Open
06. abstract.pdf40.49 kBAdobe PDFView/Open
07. introduction.pdf719.49 kBAdobe PDFView/Open
08. scope & objectives.pdf36.77 kBAdobe PDFView/Open
09. plan of work.pdf31.65 kBAdobe PDFView/Open
10. material and methods.pdf247.02 kBAdobe PDFView/Open
11. results.pdf3.14 MBAdobe PDFView/Open
12. discussion.pdf77.46 kBAdobe PDFView/Open
13. summary and conclusion.pdf35.87 kBAdobe PDFView/Open
14. references.pdf158.04 kBAdobe PDFView/Open
15. annexures.pdf41.93 kBAdobe PDFView/Open


Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: